IRIS Accounts Production v25.1.4.42 SC403447 director 31.10.23 30.10.24 30.10.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC4034472023-10-30SC4034472024-10-30SC4034472023-10-312024-10-30SC4034472022-10-30SC4034472022-10-312023-10-30SC4034472023-10-30SC403447ns15:Scotland2023-10-312024-10-30SC403447ns14:PoundSterling2023-10-312024-10-30SC403447ns10:Director12023-10-312024-10-30SC403447ns10:PrivateLimitedCompanyLtd2023-10-312024-10-30SC403447ns10:SmallEntities2023-10-312024-10-30SC403447ns10:AuditExempt-NoAccountantsReport2023-10-312024-10-30SC403447ns10:SmallCompaniesRegimeForDirectorsReport2023-10-312024-10-30SC403447ns10:SmallCompaniesRegimeForAccounts2023-10-312024-10-30SC403447ns10:FullAccounts2023-10-312024-10-30SC403447ns10:OrdinaryShareClass12023-10-312024-10-30SC403447ns10:RegisteredOffice2023-10-312024-10-30SC403447ns5:CurrentFinancialInstruments2024-10-30SC403447ns5:CurrentFinancialInstruments2023-10-30SC403447ns5:Non-currentFinancialInstruments2024-10-30SC403447ns5:Non-currentFinancialInstruments2023-10-30SC403447ns5:ShareCapital2024-10-30SC403447ns5:ShareCapital2023-10-30SC403447ns5:RetainedEarningsAccumulatedLosses2024-10-30SC403447ns5:RetainedEarningsAccumulatedLosses2023-10-30SC403447ns5:FurnitureFittings2023-10-312024-10-30SC403447ns5:ComputerEquipment2023-10-312024-10-30SC403447ns5:LandBuildings2023-10-30SC403447ns5:FurnitureFittings2023-10-30SC403447ns5:ComputerEquipment2023-10-30SC403447ns5:LandBuildings2023-10-312024-10-30SC403447ns5:LandBuildings2024-10-30SC403447ns5:FurnitureFittings2024-10-30SC403447ns5:ComputerEquipment2024-10-30SC403447ns5:LandBuildings2023-10-30SC403447ns5:FurnitureFittings2023-10-30SC403447ns5:ComputerEquipment2023-10-30SC403447ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-30SC403447ns5:WithinOneYearns5:CurrentFinancialInstruments2023-10-30SC403447ns10:OrdinaryShareClass12024-10-30SC403447ns5:RetainedEarningsAccumulatedLosses2023-10-30SC403447ns5:RetainedEarningsAccumulatedLosses2023-10-312024-10-30
REGISTERED NUMBER: SC403447 (Scotland)














UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 OCTOBER 2024

FOR

UK CLINICS GLASGOW LIMITED

UK CLINICS GLASGOW LIMITED (REGISTERED NUMBER: SC403447)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 30 October 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


UK CLINICS GLASGOW LIMITED

COMPANY INFORMATION
for the Year Ended 30 October 2024







DIRECTOR: G Kottaridis



REGISTERED OFFICE: 15 Royal Crescent
Glasgow
Lanarkshire
G3 7SL



REGISTERED NUMBER: SC403447 (Scotland)



ACCOUNTANTS: K M Stewart & Company
6 Miller Road
Ayr
KA7 2AY



BANKERS: HSBC
21 Kings Mall Street
Hammersmith
London
W6 0QF

UK CLINICS GLASGOW LIMITED (REGISTERED NUMBER: SC403447)

BALANCE SHEET
30 October 2024

2024 2023
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 866,246 861,166

CURRENT ASSETS
Debtors 5 765,336 917,043
Cash at bank and in hand 160,561 174,269
925,897 1,091,312
CREDITORS
Amounts falling due within one year 6 302,392 213,556
NET CURRENT ASSETS 623,505 877,756
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,489,751

1,738,922

CREDITORS
Amounts falling due after more than one
year

7

(443,898

)

(510,446

)

PROVISIONS FOR LIABILITIES (5,015 ) (2,846 )
NET ASSETS 1,040,838 1,225,630

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 9 1,040,738 1,225,530
SHAREHOLDERS' FUNDS 1,040,838 1,225,630

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 October 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 October 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

UK CLINICS GLASGOW LIMITED (REGISTERED NUMBER: SC403447)

BALANCE SHEET - continued
30 October 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 22 May 2025 and were signed by:





G Kottaridis - Director


UK CLINICS GLASGOW LIMITED (REGISTERED NUMBER: SC403447)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 30 October 2024

1. STATUTORY INFORMATION

UK Clinics Glasgow Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Functional currency
The financial statements are presented in British Pounds Sterling which is the functional currency. Figures are shown to the nearest whole pound.

Significant judgements and estimates
The preparation of financial statements requires the use of certain accounting estimates . It also requires the Directors to exercise judgement in applying the Companies Accounting policies. The areas requiring a higher degree of judgement, or complexity, and areas where assumptions or estimates are most significant to the financial statements, are disclosed below:

Estimation Uncertainty

Useful life of properties, plant and equipment
The Company assesses the useful life of its properties, plant and equipment and estimates the annual charge to be depreciated based on this.

Recoverability of Debtors
The Company assesses the recoverability of Debtors on an individual basis, taking into consideration payment history, and perceived liquidity. Where it is considered that there is a higher than normal risk to the recoverability of these, provision is made against the recoverability of these debts.

Stock Valuation
The Company assesses the carrying value of stock on at least an annual basis, taking into consideration when each item was purchased and the Company's ability to sell that particular item. Where it is considered the net realisable value of stock has fallen below its' original cost, a provision is made by Management against the stock value in the financial statements.

Key Judgements made in the application of Accounting Policies
a) Exemptions taken in the application of FRS 102
The Company has considered and taken advantage of the following exemptions in its application of FRS 102:
i) The Company has not revisited previous accounting estimates.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on reducing balance
Computer equipment - 33.3% on cost

UK CLINICS GLASGOW LIMITED (REGISTERED NUMBER: SC403447)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 October 2024

2. ACCOUNTING POLICIES - continued

Financial instruments
Classification
The Company believes all financial instruments are Basic Financial Instruments. Therefore, the Company recognises these in accordance with Section 11 of the Financial Reporting Standard.

Recognition and measurement
The company's debt instruments are measured at amortised cost using the effective interest rate method.

Impairment
Financial instruments are reviewed annually for impairment.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 18 (2023 - 20 ) .

UK CLINICS GLASGOW LIMITED (REGISTERED NUMBER: SC403447)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 October 2024

4. TANGIBLE FIXED ASSETS
Fixtures
Freehold and Computer
property fittings equipment Totals
£    £    £    £   
COST
At 31 October 2023 846,186 38,173 14,765 899,124
Additions - 10,160 - 10,160
At 30 October 2024 846,186 48,333 14,765 909,284
DEPRECIATION
At 31 October 2023 - 24,861 13,097 37,958
Charge for year - 3,760 1,320 5,080
At 30 October 2024 - 28,621 14,417 43,038
NET BOOK VALUE
At 30 October 2024 846,186 19,712 348 866,246
At 30 October 2023 846,186 13,312 1,668 861,166

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 1,000 6,000
Other debtors 764,336 911,043
765,336 917,043

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 58,708 49,410
Trade creditors 100,386 105,587
Taxation and social security 30,245 33,488
Other creditors 113,053 25,071
302,392 213,556

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans 443,898 510,446

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 443,898 510,446

UK CLINICS GLASGOW LIMITED (REGISTERED NUMBER: SC403447)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 October 2024

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100

9. RESERVES
Retained
earnings
£   

At 31 October 2023 1,225,530
Deficit for the year (151,792 )
Dividends (33,000 )
At 30 October 2024 1,040,738